Cerebral Palsy — The Effects of a Powered Knee Orthosis on Gait Kinematics of Children With Knee Extension Deficiency
Citation(s)
Conner BC, Schwartz MH, Lerner ZF Pilot evaluation of changes in motor control after wearable robotic resistance training in children with cerebral palsy. J Biomech. 2021 Sep 20;126:110601. doi: 10.1016/j.jbiomech.2021.110601. Epub 2021 Jul 8.
Damiano DL, Arnold AS, Steele KM, Delp SL Can strength training predictably improve gait kinematics? A pilot study on the effects of hip and knee extensor strengthening on lower-extremity alignment in cerebral palsy. Phys Ther. 2010 Feb;90(2):269-79. doi: 10.2522/ptj.20090062. Epub 2009 Dec 18.
Greene PJ, Granat MH A knee and ankle flexing hybrid orthosis for paraplegic ambulation. Med Eng Phys. 2003 Sep;25(7):539-45. doi: 10.1016/s1350-4533(03)00072-9.
Hicks JL, Schwartz MH, Arnold AS, Delp SL Crouched postures reduce the capacity of muscles to extend the hip and knee during the single-limb stance phase of gait. J Biomech. 2008;41(5):960-7. doi: 10.1016/j.jbiomech.2008.01.002. Epub 2008 Mar 4.
O'Sullivan R, Horgan F, O'Brien T, French H The natural history of crouch gait in bilateral cerebral palsy: A systematic review. Res Dev Disabil. 2018 Sep;80:84-92. doi: 10.1016/j.ridd.2018.06.013. Epub 2018 Jun 27.
Opheim A, Jahnsen R, Olsson E, Stanghelle JK Walking function, pain, and fatigue in adults with cerebral palsy: a 7-year follow-up study. Dev Med Child Neurol. 2009 May;51(5):381-8. doi: 10.1111/j.1469-8749.2008.03250.x. Epub 2008 Feb 3.
Waters RL, Mulroy S The energy expenditure of normal and pathologic gait. Gait Posture. 1999 Jul;9(3):207-31. doi: 10.1016/s0966-6362(99)00009-0.
The Effects of a Powered Knee Orthosis on Gait Kinematics of Children With Knee Extension Deficiency
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
